March 3, 2023 02:38 PM EST
Financing
Pharma
Law

UK gov­ern­ment plans to hike rev­enue claw­back rates be­gin­ning in April

Katherine Lewin

News Reporter

Ig­nor­ing warn­ing calls from phar­ma com­pa­nies and the As­so­ci­a­tion of the British Phar­ma­ceu­ti­cal In­dus­try (ABPI), the UK gov­ern­ment an­nounced it’s plan­ning …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

A service from the Financial Times